Article
Variation of ER status between primary and metastatic breast cancer and relationship to p53 expression*.
Steroids - 1 Dec 2001
Zheng W Q, Lu J, Zheng J M, Hu F X, Ni C R
Abstract excerpt
OBJECTIVE: Estrogen-dependent growth of breast cancer can be blocked by anti-estrogens. Estrogen receptor (ER) presence in breast cancer implies responsiveness to endocrine therapy. However, for those patients who ultimately develop resistance to endocrine therapy, the mechanisms remain unclear. The present study attempted to compare the expression status of ER mRNA in a series of primary breast tumors with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
